Cagrilintide: Long-Acting Amylin Analog Research Overview

Amylin (also called Islet Amyloid Polypeptide, IAPP) is a 37-amino acid pancreatic hormone co-secreted with insulin from beta cells. Endogenous amylin acts at the amylin receptor (AMY-R) — a heterodimeric receptor complex composed of the calcitonin receptor (CTR) plus receptor activity-modifying proteins (RAMPs) — to mediate postprandial satiety signaling and glucagon suppression.^[1]

Native amylin has limited utility as a research tool due to its tendency to aggregate (it's the precursor to islet amyloid in type 2 diabetes pathology). Synthetic analogs were developed to address this. Pramlintide was the first clinically used analog. Cagrilintide is a newer long-acting analog with fatty acid acylation for extended in vivo half-life suitable for preclinical research applications.^[2]

Cagrilintide is studied as a research reference compound. It has not been approved by the FDA for any human therapeutic, diagnostic, or medical purpose.

Cagrilintide structural features:

• Backbone: based on the 37-amino acid amylin sequence with substitutions

• Substitutions: designed to reduce amyloid-forming tendency (similar to the Pro substitutions used in Pramlintide)

• Fatty acid acylation: C20 fatty diacid attached via gamma-Glu linker for albumin binding

• Form: lyophilized solid

Native amylin's amyloid-forming tendency is driven by hydrophobic residues in positions 20-29. Pramlintide addressed this with three proline substitutions at positions 25, 28, and 29. Cagrilintide carries similar anti-aggregation modifications plus the fatty acid acylation that distinguishes it as long-acting.^[3]

The fatty acid acylation strategy parallels semaglutide-class GLP-1 analog design: the lipid chain reversibly binds serum albumin, providing both a circulating depot and protection from renal clearance.

Cagrilintide's research-characterized activity is at the amylin receptor complex.

The amylin receptor is unusual in its composition — it requires the calcitonin receptor (CTR) plus a receptor activity-modifying protein (RAMP1, RAMP2, or RAMP3) to form a functional receptor. This produces three amylin receptor subtypes (AMY1, AMY2, AMY3) with distinct pharmacological profiles.^[1]

Cagrilintide activates the amylin receptor complex with affinity similar to endogenous amylin, producing characteristic Gs-coupled cAMP signaling downstream.^[2]

Because the amylin receptor shares the CTR subunit with the bona fide calcitonin receptor, amylin analogs typically show some cross-activity at the calcitonin receptor. The balance of amylin-receptor vs calcitonin-receptor activity is a research variable when characterizing different synthetic analogs.^[4]

Cagrilintide and related amylin analog research spans several preclinical domains.

Rodent models of food intake regulation are the most common substrates for amylin analog research. Amylin signaling reduces meal size in animal models through central pathways involving the area postrema and the parabrachial nucleus.^[5]

Pancreatic alpha cell function and glucagon secretion in response to amylin signaling have been examined in islet preparation studies and in animal models. This research probes the glucose-counterregulatory effects of amylin beyond satiety.^[4]

The Cagrilintide + GLP-1 analog combination is among the most-studied recent peptide pairings in metabolic research. The combination engages two complementary peptide hormone systems: amylin and incretin.^[6]

Cagrilintide's fatty acid acylation provides enhanced stability in solution compared to native amylin (which is notoriously prone to aggregation). Standard peptide handling practices apply.

Lyophilized material is stored at minus 20 degrees Celsius. Brief refrigerated storage is acceptable for actively used material.

Bacteriostatic water is the standard reconstitution solvent. Reconstituted solution is used within several weeks at 4 degrees Celsius.

HPLC for purity, mass spectrometry for identity confirmation (matching the modified mass with fatty acid acylation), and endotoxin screening. Each batch of Instant Peptides Cagrilintide ships with a full Certificate of Analysis.

Instant Peptides supplies Cagrilintide as a synthetic lyophilized reference compound. Material is supplied to qualified research professionals. Not for human or animal consumption.

View the product page for current pricing and the Certificate of Analysis for the active batch.